Clinical trial · Interventional
Efficacy of Tramadol With Levobupivacaine for Modified Pectoral Nerve Block
Efficacy of Adding Tramadol as Adjunctive Analgesic With Levobupivacaine in Modified Pectoral Nerve Block for Modified Radical Mastectomy Surgery
NCT02625506CI-TRIAL-00047098completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to evaluate the addition of tramadol combined with levobupivacaine in the reduction of postoperative pain, postoperative opioid consumption after modified radical mastectomy surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Radical Mastectomy Surgery | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Levobupivacaine | Drug | — | UNRESOLVED |
| Levobupivacaine and Tramadol | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Levobupivacaine
- description
- Patients will be subjected for radical mastectomy surgery and pectoral nerve block with levobupivacaine
- interventionNames
- Drug: Levobupivacaine
- type
- ACTIVE_COMPARATOR
- label
- Levobupivacaine and Tramadol
- description
- Patients will be subjected for radical mastectomy surgery and pectoral nerve block with levobupivacaine and tramadol
- interventionNames
- Drug: Levobupivacaine and Tramadol
Primary outcomes (1)
- measure
- Postoperative pain
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * American Society of Anesthesiologists physical status I or II. * Patients scheduled for radical mastectomy surgery. Exclusion Criteria: * Severe or uncompensated cardiovascular diseases * renal diseases * Hepatic diseases * Endocrinal diseases. * Pregnancy * Postpartum * Lactating females * Allergy to study medications. * Local skin infection * Bleeding disorder * Coagulation abnormality * Spine deformity * chest deformity * Psychiatric disease
References
Publications (0)
Data not yet available
No reference posted for this study.